These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2544634)
1. Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies. Somani P J Clin Pharmacol; 1989 May; 29(5):405-12. PubMed ID: 2544634 [TBL] [Abstract][Full Text] [Related]
2. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes. Somani P; Bandyopadhyay S; Klaunig JE; Gross SA Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095 [TBL] [Abstract][Full Text] [Related]
3. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Chow MS Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951 [TBL] [Abstract][Full Text] [Related]
4. Subcellular changes of rat myocardium after treatment with amiodarone or desethylamiodarone, studied with electron microscopy. Snyder VL; Bandyopadhyay S; Collins J; Gross SA; Somani P; Didio LJ J Submicrosc Cytol Pathol; 1990 Jan; 22(1):71-8. PubMed ID: 2155704 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
7. [Amiodarone: a general antiarrhythmic agent]. Puech P Rev Prat; 1990 Oct; 40(24):2240-6. PubMed ID: 2259848 [TBL] [Abstract][Full Text] [Related]
8. Amiodarone and desethylamiodarone toxicity in isolated hepatocytes in culture. Gross SA; Bandyopadhyay S; Klaunig JE; Somani P Proc Soc Exp Biol Med; 1989 Feb; 190(2):163-9. PubMed ID: 2536944 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration. Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794 [TBL] [Abstract][Full Text] [Related]
10. [Amiodarone]. Stäubli M Schweiz Med Wochenschr; 1988 Dec; 118(50):1871-80. PubMed ID: 3065934 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Kashima A; Funahashi M; Fukumoto K; Komamura K; Kamakura S; Kitakaze M; Ueno K Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949 [TBL] [Abstract][Full Text] [Related]
13. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure. Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032 [TBL] [Abstract][Full Text] [Related]
14. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527 [TBL] [Abstract][Full Text] [Related]
15. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. Nattel S; Davies M; Quantz M Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801 [TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Singh BN Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328 [TBL] [Abstract][Full Text] [Related]
19. [Amiodarone administered orally or intravenously - the same or different drug?]. Kosior DA; Krzykwa A; Postuła M Pol Merkur Lekarski; 2013 Apr; 34(202):183-7. PubMed ID: 23745321 [TBL] [Abstract][Full Text] [Related]
20. Amiodarone-induced phospholipidosis in rat alveolar macrophages. Reasor MJ; Ogle CL; Walker ER; Kacew S Am Rev Respir Dis; 1988 Mar; 137(3):510-8. PubMed ID: 2830811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]